This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://digital.ahrq.gov/contact-us. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to digital.ahrq.gov for current information.

Clinical application of two computerized diabetes management systems: comparison with the log-book method

Authors
Ryff-de Leche A, Engler H, Nutzi E, Berger M, Berger W
Journal
Diabetes Res
Publication Date
1992 Mar
Volume
19
Issue
3
Pages
97-105
  • HIT Description: Decision support and computerized medication dosing. More info...
  • Purpose of Study: Evaluation by two studies of two computer-assisted data management systems for the management of diabetes and insulin dosing.
  • Years of study: Not Available
  • Study Design: RCT
  • Outcomes: Impact on patient safety, Impact on health care effectivness/quality
Summary:
  • Settings: Twenty (Study I) and 19 (Study II) insulin-dependent type I diabetic patients from an outpatient clinic of the University Hospital of Basel, Switzerland participated in the studies.
  • Intervention: In Study I, a computer-assisted data management system (Camit ) was compared to the conventional log-book method. In Study II, a computer-assisted data management system (ÒCamitÓ) was compared to another computer-assisted data management system (ÒCadmoÓ).
  • Evaluation Method: Measures of HbA1c, hypoglycemic events, and glucose levels.
  • HIT System: o The computer-assisted data management systems used were ÒCamit S1Ó and ÒCadmoÓ(an updated version of ÒCamit S1Ó), both commercially available computer programs.
  • Quality of Care and Patient Safety Outcome: HbA1c values decreased significantly in both studies (p 0.05). A clear decline in hypoglycemic events as well as a significant reduction of the percentage of glucose values below 4.0 mmol/l (p 0.005) and a marked increase (p 0.05) in the percentage of glucose levels in the target range (4.0-10.0 mmol/l) were observed.
The information on this page is archived and provided for reference purposes only.